FDA Approved: PACLITAXEL — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approves paclitaxel as a generic product under an original application from BluePoint Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

ORIG AP for PACLITAXEL (PACLITAXEL)